PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.parkerici.org/
Nomic and PICI Partner to Profile Protein Biomarkers in Immunotherapy Response Study
Nomic Bio and the Parker Institute for Cancer Immunotherapy (PICI) are collaborating to identify protein biomarkers linked to immunotherapy responses across various cancers.
BostonGene Sweeps 2024 Pharmaceutical Excellence Awards with AI-Powered Cancer Diagnostics Platform
BostonGene has secured five prestigious awards in the 2024 Pharmaceutical Excellence Awards, recognizing their innovative AI-powered platform for cancer diagnostics and treatment optimization.
Nomic and PICI Partner to Profile Immunotherapy Responses in RADIOHEAD Study
Nomic Bio and the Parker Institute for Cancer Immunotherapy (PICI) are collaborating to analyze protein biomarkers in immunotherapy patients.
© Copyright 2025. All Rights Reserved by MedPath